Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(n/a)
# 4,885
Out of 5,182 analysts
24
Total ratings
10%
Success rate
-31.78%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMED Minimed Group | Initiates: Overweight | $19 | $14.01 | +35.62% | 1 | Mar 31, 2026 | |
| A Agilent Technologies | Maintains: Overweight | $180 → $160 | $115.48 | +38.55% | 2 | Mar 3, 2026 | |
| WAT Waters | Maintains: Equal-Weight | $423 → $350 | $304.24 | +15.04% | 2 | Feb 23, 2026 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,550 → $1,475 | $1,259.94 | +17.07% | 2 | Feb 10, 2026 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $254.80 | +11.85% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $54.99 | +136.41% | 7 | Dec 2, 2025 | |
| DHR Danaher | Initiates: Overweight | $270 | $191.12 | +41.27% | 1 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $330.36 | -19.48% | 8 | Jul 31, 2025 |
Minimed Group
Mar 31, 2026
Initiates: Overweight
Price Target: $19
Current: $14.01
Upside: +35.62%
Agilent Technologies
Mar 3, 2026
Maintains: Overweight
Price Target: $180 → $160
Current: $115.48
Upside: +38.55%
Waters
Feb 23, 2026
Maintains: Equal-Weight
Price Target: $423 → $350
Current: $304.24
Upside: +15.04%
Mettler-Toledo International
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $1,550 → $1,475
Current: $1,259.94
Upside: +17.07%
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $254.80
Upside: +11.85%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $54.99
Upside: +136.41%
Danaher
Dec 2, 2025
Initiates: Overweight
Price Target: $270
Current: $191.12
Upside: +41.27%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $330.36
Upside: -19.48%